Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Pfizer will merge its generics unit with Mylan

The move is part of the big pharma firm’s effort to focus more on innovative medicines

by Lisa M. Jarvis
August 1, 2019 | A version of this story appeared in Volume 97, Issue 31

Article:

This article has been sent to the following recipient: